Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging

British Journal of Radiology

Volumn 80, Issue 954, 2007, Pages 437-445

  Pfannenberg, Anna Christina ^a   Aschoff, P ^a   Brechtel, K ^a   Muller M ^a   Klein, M ^a   Bares, R ^a   Claussen, C D ^a   Eschmann, S M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CHOLINE; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; IOPROMIDE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DOSIMETRY; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUROENDOCRINE TUMOR; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; RADIATION ATTENUATION; RETROSPECTIVE STUDY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548289385     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/34082277     Document Type: Article

References (25)

1. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, et al. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med 2005;46:1225-39.
2. Czernin J, Schelbert H. PET/CT imaging: facts, opinions, hopes, and questions. J Nucl Med 2004;45(Suppl):1S-3S.
3. Townsend DW, Carney JPJ, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med 2004;45(Suppl):4S-14S.
4. Schöder H, Erdi YE, Larson SM, Yeung HWD. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003;30:1419-37.
5. Cohade C, Wahl RL. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography - clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 2003;33:228-37.
6. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-9.
7. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography. N Engl J Med 2003;348:2500-7.
8. Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004;45(Suppl):82S-95S.
9. Schöder H, Larson SM, Yeung HWD. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004;45(Suppl):72S-81S.
10. Goerres GW, Schulthess GKv, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 2004;45(Suppl):66S-71S.
11. 18F-FDG PET/CT. J Nucl Med 2004; 45(Suppl):56S-65S.
12. Ratib O. PET/CT image navigation and communication. J Nucl Med 2004;45(Suppl):46S-55S.
13. Beyer T, Antoch G, Müller S, Egelhof T, Freudenberg LS, Debatin J, et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004;45(Suppl): 25S-35S.
14. 18F-FDG PET/ CT. J Nucl Med 2005;46:429-35.
15. Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Højgaard L. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005; 32:1167-75.
16. Cohade C, Osman M, Nakamoto Y, Marshall LT, Links JM, Fishman EK, et al. Linitial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003;44:412-16.
17. Dizendorf EV, Treyer V, Schulthess GKv, Hany TF. Application of oral contrast media in coregistered positron emission tomography - CT. AJR Am J Roentgenol 2002;179:477-81.
18. Goerres GW, Kamel E, Heidelberg T-NH, Schwitter MR, Burger C, Schulthess GKv. PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med 2002;29:351-60.
19. Kapoor V, McCook BM, Torok FS. An introduction to PET-CT imaging. RadioGraphics 2004;24:523-43.
20. Brechtel K, Klein M, Vogel M, Müller M, Aschoff P, Beyer T, et al. Optimized contrast enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multi-phase CT imaging. J Nucl Med 2006;47:470-6.
21. 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 2005;46:587-95.
22. Stahl A, Wieder H, Wester HJ, Piert M, Lordick F, Ott K, et al. PET/CT molecular imaging in abdominal oncology. Abdom Imaging 2004;29:388-97.
23. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 2004;29:663-8.
24. Schöder H, Yeung HWD, Larson SM. CT in PET/CT: essential features of interpretation. J Nucl Med 2005;46:1249-51.
25. Osman MM, Cohade C, Fishman EK, Wahl RL. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies; frequency in 250 patients. J Nucl Med 2005;46:1352-5.